Biogen Inc. (BIIB) Social Stream
BIOGEN INC (BIIB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIOGEN INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 27 | $502 | $259 | $368.074 | $297.13 | 23.88% |
| 2021-11-19 | 27 | $502 | $209 | $363.678 | $297.13 | 22.4% |
| 2021-11-30 | 27 | $502 | $209 | $362.607 | $297.13 | 22.04% |
| 2021-12-08 | 27 | $502 | $209 | $359.448 | $297.13 | 20.97% |
| 2021-12-09 | 28 | $502 | $209 | $355.8 | $297.13 | 19.75% |
| 2021-12-21 | 28 | $502 | $209 | $352.344 | $297.13 | 18.58% |
| 2021-12-22 | 28 | $502 | $209 | $341.466 | $297.13 | 14.92% |
| 2021-12-23 | 28 | $502 | $209 | $340.133 | $297.13 | 14.47% |
| 2022-01-07 | 28 | $500 | $209 | $332.266 | $297.13 | 11.83% |
| 2022-01-13 | 29 | $500 | $195 | $316.548 | $297.13 | 6.54% |
| 2022-01-14 | 29 | $500 | $195 | $315.58 | $297.13 | 6.21% |
| 2022-01-18 | 29 | $500 | $195 | $309.709 | $297.13 | 4.23% |
| 2022-01-28 | 30 | $500 | $195 | $305.129 | $297.13 | 2.69% |
| 2022-02-02 | 29 | $500 | $195 | $305.129 | $297.13 | 2.69% |
| 2022-02-04 | 30 | $500 | $185 | $299.483 | $297.13 | 0.79% |
| 2022-02-08 | 30 | $500 | $185 | $287.1 | $297.13 | -3.38% |
| 2022-02-15 | 30 | $500 | $185 | $286.333 | $297.13 | -3.63% |
| 2022-02-25 | 30 | $500 | $185 | $286.066 | $297.13 | -3.72% |
| 2022-03-03 | 30 | $500 | $185 | $286.766 | $297.13 | -3.49% |
| 2022-03-08 | 30 | $500 | $185 | $284.066 | $297.13 | -4.4% |
| 2022-03-11 | 30 | $500 | $185 | $284.3 | $297.13 | -4.32% |
| 2022-03-28 | 30 | $500 | $185 | $284.133 | $297.13 | -4.37% |
| 2022-03-31 | 29 | $500 | $185 | $287 | $297.13 | -3.41% |
| 2022-04-08 | 29 | $500 | $185 | $283.448 | $297.13 | -4.6% |
| 2022-04-12 | 29 | $500 | $185 | $281.275 | $297.13 | -5.34% |
| 2022-04-18 | 28 | $440 | $185 | $273.555 | $297.13 | -7.93% |
| 2022-04-22 | 28 | $440 | $185 | $272.52 | $297.13 | -8.28% |
| 2022-04-26 | 27 | $440 | $185 | $272.52 | $297.13 | -8.28% |
| 2022-05-03 | 28 | $440 | $188 | $272.624 | $297.13 | -8.25% |
| 2022-05-05 | 28 | $440 | $185 | $271.175 | $297.13 | -8.74% |
| 2022-05-09 | 28 | $440 | $185 | $269.396 | $297.13 | -9.33% |
| 2022-06-01 | 28 | $440 | $185 | $271.182 | $297.13 | -8.73% |
| 2022-06-14 | 22 | $423 | $185 | $257.35 | $297.13 | -13.39% |
| 2022-07-22 | 23 | $350 | $183 | $247.444 | $297.13 | -16.72% |
| 2022-08-13 | 22 | $350 | $183 | $247.764 | $297.13 | -16.61% |
| 2022-09-17 | 22 | $350 | $183 | $247.484 | $297.13 | -16.71% |
| 2022-09-26 | 22 | $350 | $183 | $247.284 | $297.13 | -16.78% |
| 2022-09-28 | 24 | $360 | $200 | $256.044 | $297.13 | -13.83% |
| 2022-09-30 | 24 | $360 | $200 | $273.364 | $297.13 | -8% |
| 2022-10-06 | 25 | $360 | $200 | $277.764 | $297.13 | -6.52% |
| 2022-10-07 | 25 | $360 | $202 | $280.764 | $297.13 | -5.51% |
| 2022-10-24 | 25 | $360 | $202 | $285.244 | $297.13 | -4% |
| 2022-10-26 | 26 | $360 | $202 | $287.754 | $297.13 | -3.16% |
| 2022-10-27 | 27 | $370 | $202 | $294.244 | $297.13 | -0.97% |
| 2022-11-01 | 27 | $370 | $202 | $293.503 | $297.13 | -1.22% |
| 2022-11-11 | 27 | $370 | $215.1 | $296.119 | $297.13 | -0.34% |
| 2022-11-15 | 27 | $370 | $215.1 | $301.196 | $297.13 | 1.37% |
| 2022-11-21 | 27 | $370 | $215.1 | $302.157 | $297.13 | 1.69% |
| 2022-11-30 | 27 | $370 | $215.1 | $303.273 | $297.13 | 2.07% |
| 2022-12-16 | 27 | $370 | $215.1 | $309.542 | $297.13 | 4.18% |
| 2023-01-09 | 27 | $370 | $215.1 | $308.773 | $297.13 | 3.92% |
| 2023-01-23 | 27 | $370 | $215.1 | $308.85 | $297.13 | 3.94% |
| 2023-01-24 | 27 | $370 | $215.1 | $309.619 | $297.13 | 4.2% |
| 2023-01-27 | 27 | $370 | $215.1 | $313.58 | $297.13 | 5.54% |
| 2023-02-09 | 27 | $370 | $249 | $321.708 | $297.13 | 8.27% |
| 2023-02-16 | 27 | $370 | $249 | $322.166 | $297.13 | 8.43% |
| 2023-03-14 | 27 | $370 | $249 | $323.083 | $297.13 | 8.73% |
| 2023-03-31 | 27 | $370 | $249 | $322.791 | $297.13 | 8.64% |
| 2023-04-05 | 27 | $370 | $249 | $322.375 | $297.13 | 8.5% |
| 2023-04-12 | 27 | $370 | $249 | $321.791 | $297.13 | 8.3% |
| 2023-04-17 | 27 | $370 | $263 | $322.375 | $297.13 | 8.5% |
| 2023-04-20 | 27 | $370 | $263 | $325.125 | $297.13 | 9.42% |
| 2023-04-21 | 27 | $370 | $263 | $325.333 | $297.13 | 9.49% |
| 2023-04-26 | 27 | $370 | $263 | $325.166 | $297.13 | 9.44% |
| 2023-04-27 | 27 | $371 | $263 | $326.041 | $297.13 | 9.73% |
| 2023-05-01 | 27 | $371 | $263 | $329.375 | $297.13 | 10.85% |
| 2023-05-02 | 27 | $371 | $263 | $330.416 | $297.13 | 11.2% |
| 2023-05-03 | 27 | $371 | $263 | $331.25 | $297.13 | 11.48% |
| 2023-05-04 | 27 | $371 | $263 | $332.291 | $297.13 | 11.83% |
| 2023-05-22 | 27 | $371 | $263 | $331.521 | $297.13 | 11.57% |
The Trend in the Analyst Price Target
Over the past 15 months, BIIB's average price target has gone up $47.46.
BIIB reports an average of 13.67% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-01 | 28 | 440 | 185.0 | 271.182 | 200.00 | 35.59% |
| 2022-07-22 | 24 | 350 | 183.0 | 247.444 | 206.25 | 19.97% |
| 2022-10-06 | 25 | 360 | 200.0 | 277.764 | 262.26 | 5.91% |
| 2023-01-23 | 27 | 370 | 215.1 | 308.850 | 291.93 | 5.8% |
| 2023-02-16 | 27 | 370 | 249.0 | 322.166 | 271.53 | 18.65% |
BIIB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.59 | 18 | 2 | 7 | 0 | 0 | 27 |
The Trend in the Broker Recommendations
Over the past 40 months, BIIB's average broker recommendation rating improved by 0.96.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, BIOGEN INC's number of analysts covering the stock is higher than 8481.77% of them.
- In the context of Pharmaceutical Products stocks, BIOGEN INC's average analyst price target is higher than 8371.48% of them.
- In the context of Pharmaceutical Products stocks, BIOGEN INC's upside potential (average analyst target price relative to current price) is greater than 824.38% of them.
- In terms of how BIOGEN INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -5937.88% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIOGEN INC are TECH, RGEN, and AMGN.
View All Top Stocks by Price Target
What is the outlook for BIIB? Use POWR Ratings for clearer insight into price direction.